Perspective Therapeutics (CATX)

• Market cap: $343M
• 1 day: -5.05%
• 5 days: -16.85%
• 1 month: 2.03%
• 3 months: -32.66%
• 6 months: 24.9%
• Year to date: 7.89%
• 1 year: -26.76%
• 5 years: -61.16%
• 10 years: -63.95%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Employees: 166